[{"id":"36893d7d-86e8-48f0-a407-ed95796d7b18","acronym":"","url":"https://clinicaltrials.gov/study/NCT05948865","created_at":"2023-07-17T14:08:58.925Z","updated_at":"2024-07-02T16:35:05.955Z","phase":"Phase 1","brief_title":"A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors","source_id_and_acronym":"NCT05948865","lead_sponsor":"Conjupro Biotherapeutics, Inc.","biomarkers":" EGFR • KRAS","pipe":" | ","alterations":" EGFR mutation • KRAS wild-type • RAS wild-type","tags":["EGFR • KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e EGFR mutation • KRAS wild-type • RAS wild-type"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SYS6010"],"overall_status":"Recruiting","enrollment":" Enrollment 102","initiation":"Initiation: 06/06/2023","start_date":" 06/06/2023","primary_txt":" Primary completion: 06/13/2025","primary_completion_date":" 06/13/2025","study_txt":" Completion: 12/12/2025","study_completion_date":" 12/12/2025","last_update_posted":"2024-05-03"}]